Get started
Author

Fu-Ling Chang

Observed name: F.L. Chang
ORCID: 0000-0001-6711-5820
Observed ORCID: 0000-0001-6711-5820
OpenAlex ID: A5063714867
Astragalus membranaceus–Derived Anti‐Programmed Death‐1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors
2020 · Fu-Ling Chang, Keng-Chang Tsai, et al. · BioMed Research International · 22
PDF
EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
2021 · Ting-Yi Sung, Han-Li Huang, et al. · Cell & Bioscience · 18
PDF
Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library
2020 · Yu-Ching Lee, Hsien-Te Huang, et al. · International Immunopharmacology · 13
An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
2023 · Fu-Ling Chang, Cheng-Chung Lee, et al. · Biochemical and Biophysical Research Communications · 12
Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment
2023 · Fu-Ling Chang, Keng-Chang Tsai, et al. · Heliyon · 12
Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response
2021 · Tsai-Yu Lin, Tsung-Hsun Tsai, et al. · EXPERIMENTAL ANIMALS · 8
PDF
Interaction of S17 Antibody with the Functional Binding Region of the Hepatitis B Virus Pre-S2 Epitope
2018 · Chang-Yu Chang, Fu-Ling Chang, et al. · Viral Immunology · 8
Chicken-Derived Humanized Antibody Targeting a Novel Epitope F2pep of Fibroblast Growth Factor Receptor 2: Potential Cancer Therapeutic Agent
2019 · Keng-Chang Tsai, Chao-Di Chang, et al. · ACS Omega · 7
Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies
2018 · Keng-Chang Tsai, Chen-Wei Chiang, et al. · Animal Biotechnology · 5
Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient
2024 · Shang-Ju Hsieh, Tsung-Hsun Tsai, et al. · Biochemical and Biophysical Research Communications · 4
Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer
2023 · Chen-Wei Chiang, Yun-Shih Lin, et al. · Biochemical and Biophysical Research Communications · 1
Blockade effect of avian-derived anti-VISTA antibodies on immunosuppressive responses
2022 · Yun-Shih Lin, Shang-Ju Hsieh, et al. · All Life · 1
Soluble N-terminal EphA2 fragment as a diagnostic biomarker and functional mediator of tumor progression in triple-negative breast cancer
2026 · Tsai-Yu Lin, Fu-Ling Chang, et al. · Translational Oncology
Impact of humanization scaffold design on the functional activity of FGFR2-targeting chicken scFvs
2025 · Shyi-Chun Yii, Tsai-Yu Lin, et al. · Journal of Biotechnology
Corrigendum to “Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer” [Biochem. Biophys. Res. Commun. 680 (2023) 161–170]
2023 · Chen-Wei Chiang, Yun-Shih Lin, et al. · Biochemical and Biophysical Research Communications
Rational generation of anti-fibroblast growth factor receptor 2 antibody for gastric cancer therapy
2018 · Y.C. Lee, C.D. Chang, et al. · New Biotechnology
Works count: 16
Citation count: 111
H-index: 7
I10-index: 5
Year
Topic
Type